NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
088 Region Stockholm |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 1742 | 7.0% | 338 | 1.4% | 128 | 0.5% | 2 | 0.0% | 10 | 0.0% | 59 | 0.2% | 22554 | 90.8% | 24833 | 100.0% |
ASCUS | 1278 | 35.3% | 601 | 16.6% | 314 | 8.7% | 14 | 0.4% | 8 | 0.2% | 59 | 1.6% | 1342 | 37.1% | 3616 | 100.0% |
LSIL | 738 | 30.2% | 685 | 28.1% | 358 | 14.7% | 4 | 0.2% | . | . | 20 | 0.8% | 635 | 26.0% | 2440 | 100.0% |
Atypical glandular cells/AGC | 102 | 38.3% | 40 | 15.0% | 54 | 20.3% | 11 | 4.1% | 5 | 1.9% | 4 | 1.5% | 50 | 18.8% | 266 | 100.0% |
Unclear atypia | 10 | 25.6% | 3 | 7.7% | 1 | 2.6% | . | . | 1 | 2.6% | 1 | 2.6% | 23 | 59.0% | 39 | 100.0% |
ASC-H | 110 | 22.5% | 74 | 15.1% | 207 | 42.3% | 5 | 1.0% | 7 | 1.4% | 5 | 1.0% | 81 | 16.6% | 489 | 100.0% |
HSIL | 82 | 11.0% | 77 | 10.3% | 407 | 54.5% | 6 | 0.8% | 9 | 1.2% | 6 | 0.8% | 160 | 21.4% | 747 | 100.0% |
Suspected Adenocarcinom | 4 | 7.7% | 1 | 1.9% | 6 | 11.5% | 9 | 17.3% | 12 | 23.1% | . | . | 20 | 38.5% | 52 | 100.0% |
Adenocarcinoma | 1 | 25.0% | . | . | . | . | . | . | 1 | 25.0% | . | . | 2 | 50.0% | 4 | 100.0% |
Malignant tumor with unclear origin | 1 | 9.1% | . | . | 1 | 9.1% | . | . | 4 | 36.4% | . | . | 5 | 45.5% | 11 | 100.0% |
Squamous cell cancer | . | . | 1 | 5.6% | 3 | 16.7% | . | . | 8 | 44.4% | . | . | 6 | 33.3% | 18 | 100.0% |
Totalt | 4068 | 12.5% | 1820 | 5.6% | 1479 | 4.5% | 51 | 0.2% | 65 | 0.2% | 154 | 0.5% | 24878 | 76.5% | 32515 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80001, M80703, M81403, M82003, M83803, M85603 |